US Bancorp’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-1,385
Closed -$48K 3742
2014
Q4
$48K Buy
1,385
+12
+0.9% +$391 ﹤0.01% 2561
2014
Q3
$41K Sell
1,373
-18,393
-93% -$390K ﹤0.01% 2586
2014
Q2
$397K Sell
19,766
-1,508
-7% -$34.6K ﹤0.01% 1462
2014
Q1
$578K Sell
21,274
-2,181
-9% -$57.9K ﹤0.01% 1257
2013
Q4
$487K Buy
23,455
+6,029
+35% +$114K ﹤0.01% 1317
2013
Q3
$317K Buy
+17,426
New +$315K ﹤0.01% 1464

Other funds holding AUXL

US Bancorp's AUXL Position: Q1 2015 in Review

US Bancorp sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 1,385 shares — an estimated $48K sold.

US Bancorp first reported a position in AUXL in Q3 2013 and held it in 6 quarters. The position peaked at $578K in Q1 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

  • US Bancorp reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • US Bancorp sold 1,385 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $48K.
  • US Bancorp first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q3 2013 and held it in 6 quarters.
  • US Bancorp's AUXILIUM PHARAMCEUTICALS INC position peaked at $578K in Q1 2014.
  • 1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on US Bancorp's 13F filing for Q1 2015, filed 8 May 2015.